touchNEUROLOGY joins Gabriel de Erausquin (UT Health San Antonio, TX, USA) at AAIC 2021 to discuss the Alzheimer’s Association-led Global SARS-CoV-2 Consortium and the links between long-term cognitive dysfunction, acceleration of Alzheimer’s symptoms and COVID-19.
Questions
- Could you tell us a little about the Alzheimer’s Association-led global SARS-CoV-2 consortium? (00:30-02:07)
- What were the aims and design of the cohort study you presented at AAIC? (02:07-04:01)
- What symptoms of cognitive impairment were found, and how did these correlate with olfactory symptoms and COVID-19 severity? (04:01-07:05)
- What unanswered questions remain regarding this association? (07:05-10:12)
Disclosures: Prof de Erausquin has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson.
Filmed in coverage of the 2021 AAIC Annual Meeting.
